PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Name | miRBASE accession |
---|---|
mmu-miR-29a-3p
|
MIMAT0000535 |
mmu-miR-29b-3p
|
MIMAT0000127 |
mmu-miR-29c-3p
|
MIMAT0000536 |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_45350698 | 11.38 |
ENSMUST00000087883.13
|
Col3a1
|
collagen, type III, alpha 1 |
chr5_-_134776101 | 10.05 |
ENSMUST00000015138.13
|
Eln
|
elastin |
chr4_+_140737955 | 9.90 |
ENSMUST00000071977.9
|
Mfap2
|
microfibrillar-associated protein 2 |
chr7_-_99002204 | 9.70 |
ENSMUST00000208292.2
ENSMUST00000207989.2 ENSMUST00000208749.2 ENSMUST00000169437.9 ENSMUST00000208119.2 ENSMUST00000207849.2 |
Serpinh1
|
serine (or cysteine) peptidase inhibitor, clade H, member 1 |
chr11_+_94827050 | 9.64 |
ENSMUST00000001547.8
|
Col1a1
|
collagen, type I, alpha 1 |
chrX_+_140258381 | 9.38 |
ENSMUST00000112931.8
ENSMUST00000112930.8 |
Col4a5
|
collagen, type IV, alpha 5 |
chr6_+_17281184 | 8.88 |
ENSMUST00000000058.7
|
Cav2
|
caveolin 2 |
chr1_-_90771674 | 8.66 |
ENSMUST00000097653.11
ENSMUST00000188587.7 ENSMUST00000056925.16 ENSMUST00000187753.2 |
Col6a3
|
collagen, type VI, alpha 3 |
chr13_-_12355604 | 8.51 |
ENSMUST00000168193.8
ENSMUST00000064204.14 |
Actn2
|
actinin alpha 2 |
chr2_-_125348305 | 8.29 |
ENSMUST00000028633.13
|
Fbn1
|
fibrillin 1 |
chr18_-_53551127 | 8.04 |
ENSMUST00000025419.9
|
Ppic
|
peptidylprolyl isomerase C |
chr7_-_15701395 | 8.03 |
ENSMUST00000144956.2
ENSMUST00000098799.5 |
Ehd2
|
EH-domain containing 2 |
chr3_+_68375495 | 7.95 |
ENSMUST00000182532.8
|
Schip1
|
schwannomin interacting protein 1 |
chr16_+_37597235 | 7.63 |
ENSMUST00000114763.3
|
Fstl1
|
follistatin-like 1 |
chr11_-_72302520 | 7.43 |
ENSMUST00000108500.8
ENSMUST00000050226.7 |
Smtnl2
|
smoothelin-like 2 |
chr2_+_27776428 | 7.16 |
ENSMUST00000028280.14
|
Col5a1
|
collagen, type V, alpha 1 |
chr6_+_4505493 | 7.14 |
ENSMUST00000031668.10
|
Col1a2
|
collagen, type I, alpha 2 |
chr12_-_90705212 | 7.04 |
ENSMUST00000082432.6
|
Dio2
|
deiodinase, iodothyronine, type II |
chr9_+_121589044 | 7.02 |
ENSMUST00000093772.4
|
Zfp651
|
zinc finger protein 651 |
chr11_+_77353218 | 6.81 |
ENSMUST00000102493.8
|
Coro6
|
coronin 6 |
chr4_+_47208004 | 6.72 |
ENSMUST00000082303.13
ENSMUST00000102917.11 |
Col15a1
|
collagen, type XV, alpha 1 |
chr8_+_69333143 | 6.72 |
ENSMUST00000015712.15
|
Lpl
|
lipoprotein lipase |
chr6_+_135339929 | 6.60 |
ENSMUST00000032330.16
|
Emp1
|
epithelial membrane protein 1 |
chr8_+_93553901 | 6.53 |
ENSMUST00000034187.9
|
Mmp2
|
matrix metallopeptidase 2 |
chr4_+_137196080 | 6.52 |
ENSMUST00000030547.15
ENSMUST00000171332.2 |
Hspg2
|
perlecan (heparan sulfate proteoglycan 2) |
chr11_+_63022328 | 6.42 |
ENSMUST00000018361.10
|
Pmp22
|
peripheral myelin protein 22 |
chr9_-_58111589 | 6.36 |
ENSMUST00000217578.2
ENSMUST00000114144.9 ENSMUST00000214649.2 |
Islr
Islr2
|
immunoglobulin superfamily containing leucine-rich repeat immunoglobulin superfamily containing leucine-rich repeat 2 |
chr1_+_17672117 | 6.25 |
ENSMUST00000088476.4
|
Pi15
|
peptidase inhibitor 15 |
chr1_-_45542442 | 6.03 |
ENSMUST00000086430.5
|
Col5a2
|
collagen, type V, alpha 2 |
chr15_+_11064887 | 5.99 |
ENSMUST00000061318.9
|
Adamts12
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 12 |
chr12_+_76371634 | 5.90 |
ENSMUST00000154078.3
ENSMUST00000095610.9 |
Akap5
|
A kinase (PRKA) anchor protein 5 |
chr18_-_52662917 | 5.82 |
ENSMUST00000171470.8
|
Lox
|
lysyl oxidase |
chr9_-_20726344 | 5.76 |
ENSMUST00000004201.8
|
Col5a3
|
collagen, type V, alpha 3 |
chr12_-_15866763 | 5.74 |
ENSMUST00000020922.8
ENSMUST00000221215.2 ENSMUST00000221518.2 |
Trib2
|
tribbles pseudokinase 2 |
chr3_+_137770813 | 5.73 |
ENSMUST00000163080.3
|
1110002E22Rik
|
RIKEN cDNA 1110002E22 gene |
chr8_+_11362805 | 5.70 |
ENSMUST00000033899.14
|
Col4a2
|
collagen, type IV, alpha 2 |
chr3_+_8574420 | 5.58 |
ENSMUST00000029002.9
|
Stmn2
|
stathmin-like 2 |
chr11_+_50492899 | 5.54 |
ENSMUST00000142118.3
ENSMUST00000040523.9 |
Adamts2
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 2 |
chr11_-_28534260 | 5.42 |
ENSMUST00000093253.10
ENSMUST00000109502.9 ENSMUST00000042534.15 |
Ccdc85a
|
coiled-coil domain containing 85A |
chr1_-_82564501 | 5.36 |
ENSMUST00000087050.7
|
Col4a4
|
collagen, type IV, alpha 4 |
chr1_-_186438177 | 5.34 |
ENSMUST00000045288.14
|
Tgfb2
|
transforming growth factor, beta 2 |
chr8_+_111448092 | 5.31 |
ENSMUST00000052457.15
|
Mtss2
|
MTSS I-BAR domain containing 2 |
chr17_+_33743144 | 5.28 |
ENSMUST00000087623.13
ENSMUST00000234715.2 ENSMUST00000234497.2 |
Adamts10
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 10 |
chr6_-_92683136 | 5.27 |
ENSMUST00000032093.12
|
Prickle2
|
prickle planar cell polarity protein 2 |
chr17_-_66826661 | 5.24 |
ENSMUST00000167962.2
ENSMUST00000070538.12 |
Rab12
|
RAB12, member RAS oncogene family |
chr8_-_11362731 | 5.20 |
ENSMUST00000033898.10
|
Col4a1
|
collagen, type IV, alpha 1 |
chrX_-_140257030 | 5.16 |
ENSMUST00000101205.3
|
Col4a6
|
collagen, type IV, alpha 6 |
chr9_+_102988940 | 5.05 |
ENSMUST00000189134.2
ENSMUST00000035155.8 |
Rab6b
|
RAB6B, member RAS oncogene family |
chr11_+_87989972 | 5.02 |
ENSMUST00000018522.13
|
Cuedc1
|
CUE domain containing 1 |
chr16_-_10131804 | 4.96 |
ENSMUST00000078357.5
|
Emp2
|
epithelial membrane protein 2 |
chr7_-_34353767 | 4.60 |
ENSMUST00000206501.2
ENSMUST00000108069.8 |
Kctd15
|
potassium channel tetramerisation domain containing 15 |
chrX_+_6489313 | 4.57 |
ENSMUST00000089520.3
|
Shroom4
|
shroom family member 4 |
chr8_+_83589979 | 4.56 |
ENSMUST00000078525.7
|
Rnf150
|
ring finger protein 150 |
chr9_-_58448224 | 4.55 |
ENSMUST00000039788.11
|
Cd276
|
CD276 antigen |
chr6_+_55428963 | 4.53 |
ENSMUST00000070736.12
ENSMUST00000070756.12 ENSMUST00000166962.8 |
Adcyap1r1
|
adenylate cyclase activating polypeptide 1 receptor 1 |
chr15_-_78413816 | 4.52 |
ENSMUST00000023075.9
|
C1qtnf6
|
C1q and tumor necrosis factor related protein 6 |
chr19_-_55087849 | 4.50 |
ENSMUST00000061856.6
|
Gpam
|
glycerol-3-phosphate acyltransferase, mitochondrial |
chr14_+_56062422 | 4.49 |
ENSMUST00000172271.9
|
Nfatc4
|
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
chr2_-_17735847 | 4.39 |
ENSMUST00000028080.12
|
Nebl
|
nebulette |
chr6_+_100681670 | 4.38 |
ENSMUST00000032157.9
|
Gxylt2
|
glucoside xylosyltransferase 2 |
chr17_-_46342739 | 4.34 |
ENSMUST00000024747.14
|
Vegfa
|
vascular endothelial growth factor A |
chr12_+_29988035 | 4.34 |
ENSMUST00000122328.8
ENSMUST00000118321.3 |
Pxdn
|
peroxidasin |
chr6_-_128120488 | 4.26 |
ENSMUST00000145940.8
ENSMUST00000032503.12 ENSMUST00000154375.8 ENSMUST00000112173.8 |
Tspan9
|
tetraspanin 9 |
chr5_-_135573962 | 4.21 |
ENSMUST00000060311.12
|
Hip1
|
huntingtin interacting protein 1 |
chr18_+_61178211 | 4.19 |
ENSMUST00000025522.11
ENSMUST00000115274.2 |
Pdgfrb
|
platelet derived growth factor receptor, beta polypeptide |
chr10_+_79629387 | 4.18 |
ENSMUST00000046945.13
ENSMUST00000105379.3 |
Palm
|
paralemmin |
chr8_+_31601837 | 4.16 |
ENSMUST00000046941.8
ENSMUST00000217278.2 |
Rnf122
|
ring finger protein 122 |
chr1_+_82564627 | 4.14 |
ENSMUST00000113457.9
|
Col4a3
|
collagen, type IV, alpha 3 |
chr1_+_17797257 | 4.13 |
ENSMUST00000159958.8
ENSMUST00000160305.8 ENSMUST00000095075.5 |
Crispld1
|
cysteine-rich secretory protein LCCL domain containing 1 |
chr13_+_99321241 | 4.10 |
ENSMUST00000056558.11
|
Zfp366
|
zinc finger protein 366 |
chr3_+_97565528 | 4.09 |
ENSMUST00000045743.13
|
Prkab2
|
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
chr16_+_21023505 | 4.07 |
ENSMUST00000006112.7
|
Ephb3
|
Eph receptor B3 |
chr6_-_92920466 | 4.02 |
ENSMUST00000113438.8
|
Adamts9
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9 |
chr4_+_154255187 | 4.01 |
ENSMUST00000030897.15
|
Megf6
|
multiple EGF-like-domains 6 |
chr18_-_33596792 | 4.01 |
ENSMUST00000051087.16
|
Nrep
|
neuronal regeneration related protein |
chr19_-_47452840 | 3.95 |
ENSMUST00000081619.10
|
Sh3pxd2a
|
SH3 and PX domains 2A |
chr12_+_112112621 | 3.88 |
ENSMUST00000128402.3
|
Kif26a
|
kinesin family member 26A |
chr8_+_93687561 | 3.88 |
ENSMUST00000072939.8
|
Slc6a2
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
chr9_+_56772301 | 3.88 |
ENSMUST00000035661.7
|
Cspg4
|
chondroitin sulfate proteoglycan 4 |
chr15_-_58695379 | 3.85 |
ENSMUST00000072113.6
|
Tmem65
|
transmembrane protein 65 |
chr6_-_118116062 | 3.77 |
ENSMUST00000049344.15
|
Csgalnact2
|
chondroitin sulfate N-acetylgalactosaminyltransferase 2 |
chr16_-_38620688 | 3.76 |
ENSMUST00000057767.6
|
Upk1b
|
uroplakin 1B |
chr11_-_72026547 | 3.73 |
ENSMUST00000108508.3
ENSMUST00000075258.13 |
Pitpnm3
|
PITPNM family member 3 |
chr3_+_37694094 | 3.65 |
ENSMUST00000108109.8
ENSMUST00000038569.8 ENSMUST00000108107.2 |
Spry1
|
sprouty RTK signaling antagonist 1 |
chr10_+_58230183 | 3.62 |
ENSMUST00000020077.11
|
Lims1
|
LIM and senescent cell antigen-like domains 1 |
chr3_-_87081939 | 3.53 |
ENSMUST00000159976.8
ENSMUST00000107618.9 |
Kirrel
|
kirre like nephrin family adhesion molecule 1 |
chr8_+_107662352 | 3.52 |
ENSMUST00000212524.2
ENSMUST00000047425.5 |
Sntb2
|
syntrophin, basic 2 |
chr15_-_98193995 | 3.51 |
ENSMUST00000023722.12
ENSMUST00000169721.3 |
Zfp641
|
zinc finger protein 641 |
chrX_+_98086187 | 3.45 |
ENSMUST00000036606.14
|
Stard8
|
START domain containing 8 |
chr1_-_44157916 | 3.40 |
ENSMUST00000027213.14
ENSMUST00000065767.9 |
Poglut2
|
protein O-glucosyltransferase 2 |
chr19_-_31742427 | 3.40 |
ENSMUST00000065067.14
|
Prkg1
|
protein kinase, cGMP-dependent, type I |
chr8_+_96429665 | 3.36 |
ENSMUST00000073139.14
ENSMUST00000080666.8 ENSMUST00000212160.2 |
Ndrg4
|
N-myc downstream regulated gene 4 |
chrX_-_156275231 | 3.32 |
ENSMUST00000112529.8
|
Sms
|
spermine synthase |
chr8_-_85526653 | 3.32 |
ENSMUST00000126806.2
ENSMUST00000076715.13 |
Nfix
|
nuclear factor I/X |
chr9_-_83688294 | 3.29 |
ENSMUST00000034796.14
ENSMUST00000183614.2 |
Elovl4
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
chr7_-_133826817 | 3.28 |
ENSMUST00000067680.11
|
Adam12
|
a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
chr15_+_4055865 | 3.28 |
ENSMUST00000110690.9
|
Oxct1
|
3-oxoacid CoA transferase 1 |
chr12_-_46865709 | 3.24 |
ENSMUST00000021438.8
|
Nova1
|
NOVA alternative splicing regulator 1 |
chr14_+_47120311 | 3.23 |
ENSMUST00000022386.15
ENSMUST00000228404.2 ENSMUST00000100672.11 |
Samd4
|
sterile alpha motif domain containing 4 |
chr1_-_150868802 | 3.22 |
ENSMUST00000074783.12
ENSMUST00000137197.9 |
Hmcn1
|
hemicentin 1 |
chr6_+_30738043 | 3.22 |
ENSMUST00000163949.9
ENSMUST00000124665.3 |
Mest
|
mesoderm specific transcript |
chr14_-_20027279 | 3.20 |
ENSMUST00000160013.8
|
Gng2
|
guanine nucleotide binding protein (G protein), gamma 2 |
chr9_-_30833748 | 3.15 |
ENSMUST00000065112.7
|
Adamts15
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 15 |
chr4_+_134042423 | 3.15 |
ENSMUST00000105875.8
ENSMUST00000030638.7 |
Trim63
|
tripartite motif-containing 63 |
chr1_-_82269137 | 3.10 |
ENSMUST00000069799.3
|
Irs1
|
insulin receptor substrate 1 |
chr15_-_54783357 | 3.04 |
ENSMUST00000167541.3
ENSMUST00000171545.9 ENSMUST00000041591.16 ENSMUST00000173516.8 |
Enpp2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr9_+_45749869 | 3.03 |
ENSMUST00000078111.11
ENSMUST00000034591.11 |
Bace1
|
beta-site APP cleaving enzyme 1 |
chr18_+_4921663 | 3.00 |
ENSMUST00000143254.8
|
Svil
|
supervillin |
chr17_+_64203017 | 2.94 |
ENSMUST00000000129.14
|
Fer
|
fer (fms/fps related) protein kinase |
chr13_+_93444514 | 2.91 |
ENSMUST00000079086.8
|
Homer1
|
homer scaffolding protein 1 |
chr18_+_53378734 | 2.85 |
ENSMUST00000165032.9
|
Snx24
|
sorting nexing 24 |
chr10_+_69369590 | 2.82 |
ENSMUST00000182884.8
|
Ank3
|
ankyrin 3, epithelial |
chr4_-_151129020 | 2.82 |
ENSMUST00000103204.11
|
Per3
|
period circadian clock 3 |
chr14_-_45767575 | 2.82 |
ENSMUST00000045905.15
|
Fermt2
|
fermitin family member 2 |
chr18_+_68066328 | 2.82 |
ENSMUST00000063775.5
|
Ldlrad4
|
low density lipoprotein receptor class A domain containing 4 |
chr3_+_113824181 | 2.80 |
ENSMUST00000123619.8
ENSMUST00000092155.12 |
Col11a1
|
collagen, type XI, alpha 1 |
chrX_-_94488394 | 2.73 |
ENSMUST00000084535.6
|
Amer1
|
APC membrane recruitment 1 |
chr9_+_40180726 | 2.71 |
ENSMUST00000171835.9
|
Scn3b
|
sodium channel, voltage-gated, type III, beta |
chr1_-_143652711 | 2.69 |
ENSMUST00000159879.2
|
Ro60
|
Ro60, Y RNA binding protein |
chr5_+_142946098 | 2.68 |
ENSMUST00000031565.15
ENSMUST00000198017.5 |
Fscn1
|
fascin actin-bundling protein 1 |
chr18_-_15536747 | 2.67 |
ENSMUST00000079081.8
|
Aqp4
|
aquaporin 4 |
chr5_+_135052336 | 2.65 |
ENSMUST00000005509.11
ENSMUST00000201008.4 |
Stx1a
|
syntaxin 1A (brain) |
chr4_+_43058938 | 2.64 |
ENSMUST00000207569.2
ENSMUST00000079978.13 |
Unc13b
|
unc-13 homolog B |
chr10_-_13350106 | 2.63 |
ENSMUST00000105545.12
|
Phactr2
|
phosphatase and actin regulator 2 |
chr2_-_131021905 | 2.62 |
ENSMUST00000089510.5
|
Cenpb
|
centromere protein B |
chr3_+_102903024 | 2.62 |
ENSMUST00000029447.12
|
Sike1
|
suppressor of IKBKE 1 |
chr13_+_104424359 | 2.62 |
ENSMUST00000065766.7
|
Adamts6
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 6 |
chr13_+_9326513 | 2.61 |
ENSMUST00000174552.8
|
Dip2c
|
disco interacting protein 2 homolog C |
chr11_+_60913386 | 2.60 |
ENSMUST00000089184.11
|
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chr6_+_141194886 | 2.58 |
ENSMUST00000043259.10
|
Pde3a
|
phosphodiesterase 3A, cGMP inhibited |
chr6_+_125122172 | 2.56 |
ENSMUST00000119527.8
ENSMUST00000117675.8 |
Iffo1
|
intermediate filament family orphan 1 |
chr12_+_86725459 | 2.53 |
ENSMUST00000021681.4
|
Vash1
|
vasohibin 1 |
chr13_+_21663077 | 2.51 |
ENSMUST00000062609.6
ENSMUST00000225845.2 |
Zkscan4
|
zinc finger with KRAB and SCAN domains 4 |
chr16_+_44914397 | 2.51 |
ENSMUST00000061050.6
|
Ccdc80
|
coiled-coil domain containing 80 |
chr3_-_9675130 | 2.49 |
ENSMUST00000041124.13
|
Zfp704
|
zinc finger protein 704 |
chr15_-_79718423 | 2.49 |
ENSMUST00000109623.8
ENSMUST00000109625.8 ENSMUST00000023060.13 ENSMUST00000089299.6 |
Cbx6
Npcd
|
chromobox 6 neuronal pentraxin chromo domain |
chr4_-_148021217 | 2.48 |
ENSMUST00000019199.14
|
Plod1
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
chr12_+_81678143 | 2.48 |
ENSMUST00000036116.6
|
Ttc9
|
tetratricopeptide repeat domain 9 |
chr14_+_62793175 | 2.46 |
ENSMUST00000039064.8
|
Fam124a
|
family with sequence similarity 124, member A |
chrX_+_135723420 | 2.45 |
ENSMUST00000033800.13
|
Plp1
|
proteolipid protein (myelin) 1 |
chr15_-_77191079 | 2.44 |
ENSMUST00000171751.10
|
Rbfox2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr6_-_89339581 | 2.39 |
ENSMUST00000163139.8
|
Plxna1
|
plexin A1 |
chr1_-_133849131 | 2.36 |
ENSMUST00000048432.6
|
Prelp
|
proline arginine-rich end leucine-rich repeat |
chr11_+_45946800 | 2.35 |
ENSMUST00000011400.8
|
Adam19
|
a disintegrin and metallopeptidase domain 19 (meltrin beta) |
chr4_+_97665843 | 2.31 |
ENSMUST00000075448.13
ENSMUST00000092532.13 |
Nfia
|
nuclear factor I/A |
chr5_-_125256117 | 2.30 |
ENSMUST00000086083.11
ENSMUST00000111393.8 ENSMUST00000111394.8 ENSMUST00000111402.9 ENSMUST00000111398.8 |
Ncor2
|
nuclear receptor co-repressor 2 |
chrX_+_21350783 | 2.25 |
ENSMUST00000089188.9
|
Agtr2
|
angiotensin II receptor, type 2 |
chr6_+_122796847 | 2.24 |
ENSMUST00000003238.14
|
Foxj2
|
forkhead box J2 |
chr11_-_78427061 | 2.22 |
ENSMUST00000017759.9
ENSMUST00000108277.3 |
Tnfaip1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr13_+_117356808 | 2.22 |
ENSMUST00000022242.9
|
Emb
|
embigin |
chr9_+_108782646 | 2.21 |
ENSMUST00000112070.8
|
Col7a1
|
collagen, type VII, alpha 1 |
chr11_+_67477347 | 2.20 |
ENSMUST00000108682.9
|
Gas7
|
growth arrest specific 7 |
chr13_+_55840888 | 2.19 |
ENSMUST00000057844.10
|
B230219D22Rik
|
RIKEN cDNA B230219D22 gene |
chr14_+_20979466 | 2.17 |
ENSMUST00000022369.9
|
Vcl
|
vinculin |
chr5_-_122917341 | 2.17 |
ENSMUST00000198257.5
ENSMUST00000199599.2 ENSMUST00000196742.2 ENSMUST00000200109.5 ENSMUST00000111668.8 |
Camkk2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta |
chr5_-_52723700 | 2.16 |
ENSMUST00000039750.7
|
Lgi2
|
leucine-rich repeat LGI family, member 2 |
chr14_+_84680993 | 2.16 |
ENSMUST00000071370.7
|
Pcdh17
|
protocadherin 17 |
chr7_+_48896560 | 2.14 |
ENSMUST00000184945.8
|
Nav2
|
neuron navigator 2 |
chr12_-_76869282 | 2.11 |
ENSMUST00000021459.14
|
Rab15
|
RAB15, member RAS oncogene family |
chr5_+_146321757 | 2.11 |
ENSMUST00000016143.9
|
Wasf3
|
WASP family, member 3 |
chr16_-_85698679 | 2.10 |
ENSMUST00000023611.7
|
Adamts5
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2) |
chr4_+_149602673 | 2.08 |
ENSMUST00000030839.13
|
Ctnnbip1
|
catenin beta interacting protein 1 |
chr2_-_178056251 | 2.07 |
ENSMUST00000058678.5
|
Ppp1r3d
|
protein phosphatase 1, regulatory subunit 3D |
chr9_-_83028523 | 2.04 |
ENSMUST00000187193.7
ENSMUST00000185315.7 |
Hmgn3
|
high mobility group nucleosomal binding domain 3 |
chr1_-_13062873 | 2.03 |
ENSMUST00000188454.7
|
Slco5a1
|
solute carrier organic anion transporter family, member 5A1 |
chr4_-_148529187 | 2.00 |
ENSMUST00000051633.3
|
Ubiad1
|
UbiA prenyltransferase domain containing 1 |
chr18_+_69478790 | 2.00 |
ENSMUST00000202116.4
ENSMUST00000114982.8 ENSMUST00000078486.13 ENSMUST00000202772.4 ENSMUST00000201288.4 |
Tcf4
|
transcription factor 4 |
chr4_+_21931290 | 1.95 |
ENSMUST00000029908.8
|
Faxc
|
failed axon connections homolog |
chr4_+_116078830 | 1.94 |
ENSMUST00000030464.14
|
Pik3r3
|
phosphoinositide-3-kinase regulatory subunit 3 |
chr8_+_129412135 | 1.94 |
ENSMUST00000090006.12
|
Itgb1
|
integrin beta 1 (fibronectin receptor beta) |
chr16_+_4412546 | 1.91 |
ENSMUST00000014447.13
|
Glis2
|
GLIS family zinc finger 2 |
chr2_+_29717354 | 1.91 |
ENSMUST00000091142.4
|
Urm1
|
ubiquitin related modifier 1 |
chr1_+_179788037 | 1.89 |
ENSMUST00000097453.9
ENSMUST00000111117.8 |
Cdc42bpa
|
CDC42 binding protein kinase alpha |
chr2_-_118380149 | 1.89 |
ENSMUST00000090219.13
|
Bmf
|
BCL2 modifying factor |
chr4_+_17853452 | 1.89 |
ENSMUST00000029881.10
|
Mmp16
|
matrix metallopeptidase 16 |
chr11_+_68989763 | 1.88 |
ENSMUST00000021271.14
|
Per1
|
period circadian clock 1 |
chr13_-_93636224 | 1.87 |
ENSMUST00000220513.2
ENSMUST00000065537.9 |
Jmy
|
junction-mediating and regulatory protein |
chr11_-_77380492 | 1.84 |
ENSMUST00000037593.14
ENSMUST00000092892.10 |
Ankrd13b
|
ankyrin repeat domain 13b |
chr12_+_85520652 | 1.82 |
ENSMUST00000021674.7
|
Fos
|
FBJ osteosarcoma oncogene |
chr2_+_59442378 | 1.81 |
ENSMUST00000112568.8
ENSMUST00000037526.11 |
Tanc1
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
chrX_-_102865546 | 1.76 |
ENSMUST00000042664.10
|
Slc16a2
|
solute carrier family 16 (monocarboxylic acid transporters), member 2 |
chr13_-_43457626 | 1.73 |
ENSMUST00000055341.7
|
Gfod1
|
glucose-fructose oxidoreductase domain containing 1 |
chrX_+_5959507 | 1.73 |
ENSMUST00000103007.4
|
Nudt11
|
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
chr13_-_43324937 | 1.73 |
ENSMUST00000222160.2
ENSMUST00000179852.9 ENSMUST00000021797.9 |
Tbc1d7
|
TBC1 domain family, member 7 |
chr3_-_72965136 | 1.72 |
ENSMUST00000059407.9
|
Slitrk3
|
SLIT and NTRK-like family, member 3 |
chr17_-_68311073 | 1.70 |
ENSMUST00000024840.12
|
Arhgap28
|
Rho GTPase activating protein 28 |
chr8_-_26609153 | 1.70 |
ENSMUST00000037182.14
|
Hook3
|
hook microtubule tethering protein 3 |
chr6_+_38639945 | 1.69 |
ENSMUST00000114874.5
|
Clec2l
|
C-type lectin domain family 2, member L |
chr2_-_34716083 | 1.67 |
ENSMUST00000113077.8
ENSMUST00000028220.10 |
Fbxw2
|
F-box and WD-40 domain protein 2 |
chr10_-_81262948 | 1.66 |
ENSMUST00000078185.14
ENSMUST00000020461.15 ENSMUST00000105321.10 |
Nfic
|
nuclear factor I/C |
chr6_-_147165623 | 1.64 |
ENSMUST00000052296.9
ENSMUST00000204197.2 |
Pthlh
|
parathyroid hormone-like peptide |
chr19_+_10366753 | 1.62 |
ENSMUST00000169121.9
ENSMUST00000076968.11 ENSMUST00000235479.2 ENSMUST00000223586.2 ENSMUST00000235784.2 ENSMUST00000224135.3 ENSMUST00000225452.3 ENSMUST00000237366.2 |
Syt7
|
synaptotagmin VII |
chr6_-_72416531 | 1.62 |
ENSMUST00000205335.2
ENSMUST00000206692.2 ENSMUST00000059472.10 |
Mat2a
|
methionine adenosyltransferase II, alpha |
chr6_-_29179583 | 1.61 |
ENSMUST00000159200.2
|
Prrt4
|
proline-rich transmembrane protein 4 |
chr13_+_55253102 | 1.61 |
ENSMUST00000161315.8
ENSMUST00000021937.12 ENSMUST00000159278.8 ENSMUST00000159147.8 ENSMUST00000161077.2 |
Zfp346
|
zinc finger protein 346 |
chr11_-_5102218 | 1.60 |
ENSMUST00000163299.8
ENSMUST00000062821.13 |
Emid1
|
EMI domain containing 1 |
chr8_-_45835234 | 1.60 |
ENSMUST00000093526.13
|
Fam149a
|
family with sequence similarity 149, member A |
chr4_-_41640321 | 1.56 |
ENSMUST00000127306.2
|
Enho
|
energy homeostasis associated |
chr11_-_90281721 | 1.56 |
ENSMUST00000004051.8
|
Hlf
|
hepatic leukemia factor |
chrX_-_94701983 | 1.55 |
ENSMUST00000119640.8
ENSMUST00000120620.8 ENSMUST00000044382.7 |
Zc4h2
|
zinc finger, C4H2 domain containing |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 16.5 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
3.3 | 13.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
2.3 | 11.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.1 | 8.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
2.0 | 16.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.9 | 5.7 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.8 | 5.3 | GO:1905006 | positive regulation of activation-induced cell death of T cells(GO:0070237) negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905006) |
1.8 | 7.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
1.7 | 8.5 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
1.5 | 1.5 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
1.5 | 6.0 | GO:1902202 | proteoglycan catabolic process(GO:0030167) regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
1.4 | 5.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.3 | 29.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.3 | 8.9 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
1.1 | 4.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.1 | 3.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.1 | 5.3 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
1.1 | 4.2 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
1.0 | 3.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.0 | 4.2 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.0 | 5.9 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.0 | 5.9 | GO:0036394 | amylase secretion(GO:0036394) |
1.0 | 3.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.0 | 6.7 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.9 | 2.6 | GO:0009629 | response to gravity(GO:0009629) |
0.8 | 3.8 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.7 | 2.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.7 | 2.8 | GO:0035989 | tendon development(GO:0035989) |
0.7 | 3.4 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.7 | 1.4 | GO:2000331 | regulation of terminal button organization(GO:2000331) |
0.7 | 2.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.7 | 7.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.7 | 3.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.7 | 4.6 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.6 | 1.9 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.6 | 1.9 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.6 | 2.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.6 | 1.9 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.6 | 4.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.6 | 18.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 1.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.6 | 2.3 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.5 | 1.6 | GO:0060618 | nipple development(GO:0060618) |
0.5 | 1.6 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.5 | 2.7 | GO:0070295 | renal water absorption(GO:0070295) |
0.5 | 2.6 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.5 | 3.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.5 | 1.5 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
0.5 | 2.5 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.5 | 5.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 7.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.5 | 1.4 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.5 | 2.8 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.5 | 1.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 2.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.4 | 1.7 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.4 | 1.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.4 | 2.9 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Fc-epsilon receptor signaling pathway(GO:0038095) Kit signaling pathway(GO:0038109) |
0.4 | 4.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 5.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 4.2 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.4 | 3.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 9.4 | GO:0001553 | luteinization(GO:0001553) |
0.4 | 2.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 1.1 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.4 | 3.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.4 | 1.1 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.3 | 2.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.3 | 2.7 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.3 | 1.0 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.3 | 3.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 1.0 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.3 | 7.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.3 | 1.9 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 1.9 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 2.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 3.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 0.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 0.6 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.3 | 3.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 2.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.3 | 1.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 2.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 1.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 1.0 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 1.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.7 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.2 | 2.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 7.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.5 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 1.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 2.8 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.2 | 4.5 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 4.4 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.2 | 1.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 1.2 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.2 | 9.9 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.2 | 0.8 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.2 | 0.6 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.2 | 3.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 1.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 4.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 1.2 | GO:1904073 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.2 | 4.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.5 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 0.5 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) negative regulation of serotonin secretion(GO:0014063) |
0.2 | 2.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 1.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 1.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.5 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.2 | 2.3 | GO:0072189 | ureter development(GO:0072189) |
0.2 | 1.7 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 1.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.1 | 1.4 | GO:1904645 | response to beta-amyloid(GO:1904645) |
0.1 | 3.8 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 2.9 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 4.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.3 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.1 | 2.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 1.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 3.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.3 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 5.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 2.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 1.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 1.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 1.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 3.9 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.1 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
0.1 | 0.6 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 1.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 1.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 2.1 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 5.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 1.7 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.1 | 0.8 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.1 | 1.9 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.1 | 2.9 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.3 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.1 | 5.3 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 2.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 3.1 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.3 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 3.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 5.9 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 0.3 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 1.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 2.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.2 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.1 | 10.9 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 1.8 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 1.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.3 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.1 | 0.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 1.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 1.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.8 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 3.2 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.1 | 1.1 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 1.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 1.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 2.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 3.5 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 1.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.4 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.7 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.8 | GO:0015809 | arginine transport(GO:0015809) |
0.0 | 0.4 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 2.6 | GO:0035904 | aorta development(GO:0035904) |
0.0 | 2.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.6 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 1.4 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.0 | 1.2 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.0 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 1.8 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 1.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.4 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.7 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.0 | 0.9 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 1.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 1.3 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 5.1 | GO:0042594 | response to starvation(GO:0042594) |
0.0 | 4.6 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.0 | 1.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 1.8 | GO:0051017 | actin filament bundle assembly(GO:0051017) |
0.0 | 6.9 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 1.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
0.0 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 1.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.8 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.0 | 0.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.0 | 0.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 1.3 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 0.3 | GO:0060840 | artery development(GO:0060840) |
0.0 | 1.0 | GO:0051289 | protein homotetramerization(GO:0051289) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 18.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
5.6 | 16.8 | GO:0005584 | collagen type I trimer(GO:0005584) |
5.0 | 34.9 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
2.0 | 10.0 | GO:0071953 | elastic fiber(GO:0071953) |
1.4 | 23.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
1.2 | 8.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.0 | 3.1 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.9 | 11.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.8 | 4.2 | GO:0098890 | extrinsic component of postsynaptic membrane(GO:0098890) |
0.5 | 1.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.5 | 2.7 | GO:0044393 | microspike(GO:0044393) |
0.5 | 2.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.5 | 3.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.3 | GO:1990879 | CST complex(GO:1990879) |
0.4 | 2.6 | GO:0044305 | calyx of Held(GO:0044305) |
0.4 | 1.8 | GO:0035976 | AP1 complex(GO:0035976) |
0.3 | 32.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 5.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 3.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 4.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 6.7 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 12.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 8.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 4.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 1.7 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 6.5 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 0.7 | GO:0097635 | Atg12-Atg5-Atg16 complex(GO:0034274) extrinsic component of autophagosome membrane(GO:0097635) |
0.2 | 0.7 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
0.2 | 5.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.5 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 1.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 2.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 16.9 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 0.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.2 | 10.9 | GO:0043034 | costamere(GO:0043034) |
0.2 | 5.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 9.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 1.6 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 32.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 2.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 4.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 3.1 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 2.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 3.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 7.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 4.0 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.7 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 1.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 6.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 3.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 1.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 5.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 6.9 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 3.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 2.4 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 1.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 1.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.1 | GO:0070992 | translation initiation complex(GO:0070992) |
0.0 | 5.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 4.2 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 15.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.0 | GO:0031672 | A band(GO:0031672) |
0.0 | 1.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 1.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 6.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 1.1 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 1.0 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 3.6 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 7.5 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 1.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.7 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.6 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.6 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 1.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 1.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.8 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 1.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 1.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 1.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 1.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.3 | GO:0070069 | cytochrome complex(GO:0070069) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 41.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.0 | 9.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.8 | 7.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.7 | 8.5 | GO:0051373 | FATZ binding(GO:0051373) |
1.4 | 4.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
1.3 | 3.9 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
1.1 | 8.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.1 | 4.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.1 | 6.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.1 | 45.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.9 | 3.8 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.9 | 5.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.9 | 2.6 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.8 | 3.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.7 | 2.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.6 | 3.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.6 | 4.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.6 | 3.4 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.6 | 4.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 3.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.5 | 1.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 2.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 1.4 | GO:0050510 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.5 | 2.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 2.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) |
0.4 | 4.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 1.6 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.4 | 6.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 1.1 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
0.4 | 4.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 2.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 4.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 3.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 8.9 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.3 | 6.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 9.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 5.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 3.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 2.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 2.7 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 1.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 1.0 | GO:0043532 | angiostatin binding(GO:0043532) |
0.2 | 1.7 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.2 | 3.1 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.7 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.2 | 28.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 1.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 0.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 1.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 3.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 1.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 2.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 2.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 5.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 1.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 4.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 5.8 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.2 | 2.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 3.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 3.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.9 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 1.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 2.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.6 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 2.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 1.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 1.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 2.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 3.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 2.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 2.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 4.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 2.0 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 1.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 2.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 9.3 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 2.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 2.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 1.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 1.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.8 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 0.5 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.1 | 2.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 4.6 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 2.3 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 2.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 4.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 2.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.2 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 6.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 3.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 5.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 2.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 8.2 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 14.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 6.0 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 1.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 2.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 3.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.3 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 1.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 1.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 1.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 2.1 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 8.8 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 1.4 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.0 | 14.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 1.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 1.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 1.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 5.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 9.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 1.6 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 96.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 4.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 8.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 17.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 9.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 5.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 4.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 3.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 4.9 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 55.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 4.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 9.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 31.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 6.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 5.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 6.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 4.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 3.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 4.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 3.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 5.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 2.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 2.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 3.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 9.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 4.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 2.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 115.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 5.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 3.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.5 | 12.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 9.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 7.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 6.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 4.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 11.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 8.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 5.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 7.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 2.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 4.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 3.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 2.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 6.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 7.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 3.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 2.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 3.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 0.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 4.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 2.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 8.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 2.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 5.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 3.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 2.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 4.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 2.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 2.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 3.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 5.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 4.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 3.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 1.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 2.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 1.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 4.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 2.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.9 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |